Bionomics Results Presentation Deck
Social Anxiety Disorder Represents a Large Segment of the Anxiety Market
No FDA-approved fast-acting medications for as-needed treatment
14
Social Anxiety Disorder (SAD), or Social Phobia, is
a significant and persistent fear of social and
performance-related situations
Includes anxiety from everyday social situations;
a reoccurring episodic disorder
Amongst the largest mental health conditions with
lifetime prevalence affecting >31M Americans.
Triggers that exacerbate anxiety can occur at any
time
~7M
36% of adults
show SAD
symptoms >10
years
Opportunity
for BNC210
Sources:
US Census Bureau. https://www.census.gov/library/stories/2021/08/united-states-adult-population-grew-faster-than-nations-total-population-from-2010-to-2020.html
NIMH. "Social Anxiety Disorder" data from 2017 National Comorbidity Survey (NCS). https://www.nimh.nih.gov/health/statistics/social-anxiety-disorder.shtml
Anxiety and Depression Association of America (ADAA). "Social Anxiety Disorder - Understand the Facts" https://adaa.org/understanding-anxiety/social-anxiety-disorder
~18M
31M
7.1%
prevalence
in adults
12.1% of adults
at some point in
their lives
BionomicsView entire presentation